Journal of Heterocyclic Chemistry · 2020 · 25 citations · 40 references
MedicineMedicinal ChemistryPharmacologyDrug DiscoveryMolecular PharmacologyStructure-activity RelationshipsGabaergic PharmacologyHypnotic AgentsSedative PharmacologySedative-hypnotic PharmacologyActivitiesGreen Heterocycle SynthesisGreen SynthesisMolecular Docking AnalysisPharmacological PotencyPharmacological ScreeningSedative-hypnotic MechanismsStereochemical Structure - Activity Relationship
Abstract 4‐Amino‐5‐mercapto‐4 H ‐1,2,4‐triazole derivative 1 was used as a key intermediate for the preparation of 1,2,4‐triazolo[3,4‐b][1,3,4]thiadiazepine derivatives 5a‐d , 12a‐g , and 16 via reactions with the appropriate chalcones 2a‐d , α,β‐unsaturated carbonitrile derivatives 9a‐g and 13 , respectively. The identity of the synthesized compounds was elucidated via their spectral data and elemental analysis. Moreover, the sedative‐hypnotic activity of the newly synthesized compounds were evaluated and showed excellent activities especially compounds 12b , 12f , and 16 . Also, their structure activity relationship (SAR) was clearly demonstrated and showed that the electron‐donating groups enhance activities while electron‐withdrawing groups decrease activities. The molecular docking of the most active derivative 16 against γ‐amino butyric acid (GABA) receptor was performed by the MOE 2014 0901program. The acquired outcomes demonstrated that the most active compounds could be a helpful model for future structure, adjustment, and examination to build more active analogs.
40
Benzodiazepine actions mediated by specific γ-aminobutyric acidA receptor subtypes
Uwe Rudolph, Florence Crestani, Dietmar Benke et al. · Nature · 1999 · 1.2K citations
Medicine, Neuroscience, Pharmacology +14
Basic and Clinical Pharmacology
Dianna Bashline · AORN Journal · 1991 · 507 citations
Arun M. Isloor, Balakrishna Kalluraya, Prashanth Shetty · European Journal of Medicinal Chemistry · 2009 · 238 citations